• At the same time, patients are presenting with greater comorbidity burden. Analysis of Mayo Clinic Total Joint Registry data showed a 22% increase in the mean Charlson Comorbidity Index (CCI) score between 1993 and 2005 among patients undergoing primary THA with the odds of presenting with a high score (≥ 3) greater in the later time period ('02-'05) vs earlier ('93-'95) (OR = 1.32; 95% CI 1.07-1.63) 1
• While other studies have evaluated the association between presence of individual comorbidities and outcomes following elective orthopedic procedures, none have evaluated the full set of clinical and economic outcomes while controlling for a robust set of patient and hospital characteristics
• This study evaluated the correlation between patient comorbidity status as measured by the CCI and patient outcomes, hospital length of stay (LOS), and total cost following elective orthopedic procedures • Comparing healthy patients (CCI of 0) to those with a high score (CCI ≥3) the incidence of transfusion increased from 12.2% to 23.8% for TKA, 18.0% to 33.3% for THA, and 8.7% to 21.8% for fusion (all P<.001)
• For each cohort, the incidence of any complication increased significantly with greater comorbidity burden (all P<.001), Figure 1 • In logistic regressions controlling for age, gender, region, hospital size, academic status, payor, and procedure year, increasing CCI was associated with increased odds of any inpatient complication, Table 2 • Compared to healthy patients, those with high CCI score (CCI ≥3) had an increased hospital LOS by 0.9 days for TKA, 1.4 days for THA, and 2.3 days for spinal fusion. This was associated with significantly greater total hospitalization cost, Figure 2 • In multivariate analysis, those with high CCI score (CCI ≥3 ) vs. a score of zero had 1.14, 1.19, and 1.18 times greater total adjusted mean hospitalization cost for the TKA, THA, and fusion cohorts (incremental costs of $1,728; $2,463; $3,576 respectively)
• Given that our dataset was limited to the inpatient setting, we were unable to review historical diagnoses. Therefore, the estimate of patient comorbidity burden may be an underestimate, as it is possible not all diagnoses that comprise the CCI score were recorded during a patient's hospital stay
• While comprising a relatively small proportion of all patients undergoing elective orthopedic procedures, those with CCI scores ≥ 3 were associated with a significantly higher hospitalization cost burden
• With patient comorbidity burden growing nationally, the results of this study suggest that further examination of algorithms of care and selection criteria is warranted for comorbid patients undergoing elective orthopedic procedures in order to achieve the same outcomes seen by healthy patients
